Stock Tip Tuesday…

Alright fellas, it’s Tuesday and time for another stock tip that could make you some cheddar. Today we’re talking about Cannabix Technologies (OTC: $BLOZF ( ▲ 5.59% ) / CSE: $BLO) - a company that’s solving one of the biggest problems in the cannabis legalization wave.

^_NEWS
Cannabix Technologies Is Developing the THC Detection Solution Law Enforcement Has Been Waiting For

Remember Cannabis stocks in 2018 when Canada legalized? Yes, one of the most legendary bull markets of all time. Well, buckle up, because we may be about to enter an even more savage cannabis bull market as the USA is on the fence about a nation wide legalization, and even Germany just pulled the trigger. With the size of the US & German market making Canada’s look like a corner store, this potential upcoming cannabis bull market could turn Garbage men to quants over night.

And we aren't chasing the next big grower, we are eyeing the inevitable, the infrastructure play. And that’s where Cannabix Technologies Inc comes in.

The Problem Nobody’s Talking About

Here’s the deal - as cannabis continues to be legalized across more and more states, how will law enforcement accurately test for cannabis impairment? They need to be able to detect for recent use, meaning the time window, typically 1-3 hours after lighting up or taking an edible. Blood tests can detect THC for many days after use. Urine tests show usage from weeks ago. Cops, employers, and insurance companies need answers about recent weed consumption. Drug testing methods like urine, hair and spit don’t provide fair and relevant results. 

Currently, 18 states plus Washington D.C. have full legalization, with another 18 states allowing medical cannabis. Two-thirds of Americans support legalization, and the federal government is considering moving marijuana from Schedule I to Schedule III. The writing’s on the wall - cannabis is going mainstream. 

But here’s what most investors don’t realize: every single state that legalizes cannabis creates a massive new market for testing technology. Law enforcement needs it. Employers demand it. Insurance companies require it. And right now, there’s no good solution.

Why Cannabix Technologies Cannabis Testing Changes Everything

Cannabix Technologies OTC: $BLOZF ( ▲ 5.59% ) / CSE: $BLO.CN has developed something called the Marijuana Breath Test (MBT) - and it’s exactly what it sounds like. Think breathalyzer for weed, but way more sophisticated.

Their Marijuana Breath Test (MBT) technology works to collect and detect cannabis use within 1-3 hours after smoking or edibles, which is the actual impairment window. The handheld device collects a standardized breath sample in less than 2 minutes, requires no medical training to operate, the sample is then analyzed using gold standard mass spectrometry, the kind of real-time results that law enforcement and employers actually need.

The company has partnered with Omega Laboratories for analysis, creating a complete testing ecosystem. It’s non-invasive, fast turnaround, and addresses the exact problem that’s been holding back broader cannabis acceptance in workplace and public safety contexts.

This isn’t some pie-in-the-sky technology either. The Cannabis Testing Technology is real, it’s been developed, and they’re positioning for commercial rollout as the regulatory environment catches up.

The Market Opportunity is Massive

Think about the scale here. Every police department in legal states needs this technology. Every major employer in cannabis-legal jurisdictions wants workplace testing capabilities. Insurance companies are demanding better impairment detection before they’ll provide coverage.

The federal recommendation to move cannabis to Schedule III would make research easier and reduce legal penalties while maintaining federal oversight. That’s actually perfect for a testing company - it legitimizes the market while creating regulatory demand for their solutions.

Cannabis-related hospitalizations are increasing as usage grows, creating additional demand from healthcare providers who need to understand patient impairment levels. The THC Breath Detection market is set to explode as legalization expands and institutions demand practical testing solutions.

The Investment Thesis

Cannabix Technologies Inc Stock OTC: $BLOZF ( ▲ 5.59% ) / CSE:$BLO is trading around attractive levels for a company positioned at the center of a massive infrastructure buildout. They’re not competing with dozens of cannabis growers or fighting for dispensary licenses. They’re solving a fundamental problem that every legal cannabis market needs addressed.

The company has been investing heavily in R&D, with operating expenses growing from CAD 2.28 million in 2022 to CAD 5.95 million in 2025. They aren’t burning cash - they are building the technology infrastructure for a multi-billion dollar market opportunity.

Yes, they’re pre-revenue right now, which means higher risk. But it also means you’re getting in before the commercial rollout begins. When law enforcement agencies and major employers start adopting their Cannabis Testing Technology, the revenue ramp could be dramatic.

The company trades on multiple exchanges (OTC: $BLOZF ( ▲ 5.59% ) , CSE: $BLO), providing liquidity and legitimacy that many cannabis plays lack.

Bottom Line

Ticker: $BLOZF (OTC) / $BLO (CSE)

Cannabix Technologies Inc offers leveraged exposure to the cannabis legalization infrastructure buildout. Their THC Breath Detection technology addresses a critical market need that’s only growing as more states legalize cannabis.

This isn’t a safe dividend play - it’s a high-risk, high-reward bet on cannabis testing technology becoming essential infrastructure. If they execute, the upside could be massive. If they don’t, you could lose everything.

Do your own research, don’t bet the farm, but if you’re looking for a different angle on the cannabis story, this might be worth a look.

If you are interested in reading more, they just got featured on Zero Hedge. Click the link to learn more: $BLOZF Zero Hedge Article

Thank you
That’s All Folks

Thank you for reading. Like usual. Not financial advice.

We own don’t own any stock in Cannabix Technologies Inc but we may buy or sell at any given moment.

Cheers,

Legal
Disclaimer

^{The material contained in this newsletter and any related communications (including social media posts) is intended strictly for informational and marketing purposes. It does not constitute investment advice, an offer to buy or sell securities, or a recommendation of any kind. No securities regulatory authority has reviewed or approved the content of this communication. All statements, projections, and opinions expressed are based on publicly available information believed to be accurate at the time of publication. Black Swan Solutions Inc DBA VHLA Media Inc (“we,” “our,” or “us”) does not warrant the completeness, accuracy, or timeliness of the content and expressly disclaims any obligation to update it. The information presented may include forward-looking statements that are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied. Black Swan Solutions Inc DBA VHLA Media Inc is not registered as an investment advisor, broker-dealer, or analyst with any securities regulatory authority in any jurisdiction. We do not offer investment analysis or provide personalized investment advice. We have been compensated CAD $100,000 + GST for a marketing campaign promoting Cannabix Technologies Inc. This includes newsletter distribution, social media posts, and related promotional content across various platforms. Black Swan Solutions Inc DBA VHLA Media Inc and/or its principals do not currently own shares of Cannabix Technologies Inc, but may buy or sell shares in the open market at any time without prior notice. This may create a potential conflict of interest that readers should consider when evaluating the content. Investing in securities, especially micro-cap and OTC-listed companies, involves significant risk, including the potential loss of your entire investment. These securities are highly speculative and may be subject to wide fluctuations in price and liquidity. You are strongly encouraged to conduct your own due diligence and consult with a registered investment advisor or licensed financial professional before making any investment decisions.}